Brightlands Health Campus Maastricht

Startup develops new vaccine against hepatitis b

It has been a mystery to scientists for years: being well vaccinated against hepatitis B, but still being able to become infected with the HBV virus. CyTuVax from Maastricht is currently testing a...

Loading

Don’t miss a thing!

Every week we collect the best stories about innovation especially for you!
Sign up for our newsletter now, so you’ll never miss anything again.